Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders in Group Format in Spain: Results of a Noninferiority Randomized Controlled Trial at 15 Months after Treatment Onset
Table 2
Frequency and differences between groups in diagnostic comorbidity over time.
T2
T3
T4
T5
(%)
(%)
(%)
(%)
Main diagnosis
Meets diagnostic criteria
UP
53 (62.4)
5.98
0.014
25 (41.7)
19.56
≤0.001
30 (46.9)
12.12
≤0.001
17 (31.5)
13.36
≤0.001
TAU
60 (80.0)
50 (80.6)
45 (77.6)
29 (69.1)
Does not meet diagnostic criteria
UP
32 (37.6)
35 (58.3)
34 (53.1)
37 (68.5)
TAU
15 (20.0)
12 (19.4)
13 (22.4)
13 (30.9)
Secondary diagnosis
Meets diagnostic criteria
UP
9 (39.1)
10.42
≤0.001
6 (35.3)
3.44
0.064
5 (33.3)
4.30
0.038
3 (20.0)
6.63
0.010
TAU
13 (92.9)
6 (75.0)
5 (83.3)
6 (75.0)
Does not meet diagnostic criteria
UP
14 (60.9)
11 (64.7)
10 (66.7)
12 (80.0)
TAU
1 (7.1)
2 (25.0)
1 (16.7)
2 (25.0)
Note: UP: Unified Protocol; TAU: treatment as usual; T2: 3 months after treatment onset; T3: 6 months after treatment onset; T4: 9 months after treatment onset; T5: 15 months after treatment onset. values < 0.05 are in bold.
